DiaPharma

Executive Summary

DiaPharma, founded in 1990 and based in West Chester, Ohio, is a privately held specialty diagnostics and research products company with over 25 years of experience. The company offers a comprehensive portfolio of assay kits, reagents, antibodies, and instrumentation focused on hemostasis, liver disease, hematology, and cell death research. DiaPharma differentiates itself through strong personalized scientific support and technical expertise, catering to the specific needs of clinical and research customers. Despite its niche focus and established reputation, the company operates in a competitive diagnostics market and lacks recent public funding or product launch announcements, which may limit near-term growth visibility.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation hemostasis assay kit70% success
• TBDStrategic distribution partnership for liver disease biomarkers50% success
• Q4 2026FDA clearance of new diagnostic test for cell death detection40% success